Finally revealing the positive P.R. in their announcements.Quite a change from their usual format.Telling it as it is,the majority view,not the usual vocal minority opinion.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling